| P50 | author | Silvia de Sanjosé | Q47367042 |
| | Francesc Xavier Bosch José | Q56376448 |
| | Raquel Ibáñez | Q57551631 |
| P2093 | author name string | Cristina Gutiérrez | |
| | María Alejo | |
| | Anna Torrent | |
| | Núria Baixeras | |
| | Belén Lloveras | |
| | Josefina Autonell | |
| | Clara Martí | |
| | Judit Moreno-Crespi | |
| | Montserrat Fibla | |
| | Amparo Pascual | |
| | Montserrat Sardà | |
| | Nayade Crespo | |
| | Pilar Pique | |
| P2860 | cites work | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer | Q24607403 |
| | The causal relation between human papillomavirus and cervical cancer | Q24673148 |
| | Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. | Q33856842 |
| | Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial. | Q34051722 |
| | The 2001 Bethesda System: terminology for reporting results of cervical cytology | Q34124761 |
| | Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral | Q34153160 |
| | Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases | Q34627886 |
| | Human papillomavirus and Papanicolaou tests to screen for cervical cancer | Q34702284 |
| | Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme | Q35324720 |
| | Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study | Q37135912 |
| | Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study | Q37281729 |
| | Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries | Q37291430 |
| | Primary HPV screening for cervical cancer prevention: results from European trials | Q37630357 |
| | Interlaboratory reproducibility and proficiency testing within the human papillomavirus cervical cancer screening program in Catalonia, Spain. | Q37713769 |
| | Screening history in women with cervical cancer in a Danish population-based screening program | Q37805059 |
| | Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer | Q38064070 |
| | Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials | Q38160099 |
| | Frequency of cervical intraepithelial neoplasia treatment in a well-screened population | Q39736075 |
| | Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany--experience over 3 years | Q43418991 |
| | Validation of high-risk HPV tests for primary cervical screening | Q43762516 |
| | Sentinel Pap smears in 261 invasive cervical cancer patients in Italy | Q43762676 |
| | Coverage of cervical cancer screening in Catalonia, Spain (2008-2011) | Q43852225 |
| | Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening | Q44876752 |
| | Cost-effectiveness of human papillomavirus vaccination and screening in Spain | Q46109665 |
| | Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study | Q46295268 |
| | Cervical cancer incidence in Denmark over six decades (1943-2002). | Q50543191 |
| | Cobertura del cribado de cáncer de cuello uterino en Cataluña (2008-2011) | Q57551626 |
| | Screening history of women with invasive cervical cancer in north-east Italy | Q58280467 |
| | Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial | Q61626075 |
| | Invasive cervical cancer: a failure of screening | Q61897418 |
| | Screening history of women in Malmö with invasive cervical cancer | Q79516632 |
| | Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial | Q81404025 |
| | Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial | Q82586477 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 574 | |
| P577 | publication date | 2014-08-08 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Protecting the underscreened women in developed countries: the value of HPV test | |
| P478 | volume | 14 | |